Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $342.08 million. The enterprise value is $290.39 million.
Important Dates
The next estimated earnings date is Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 52.87 million shares outstanding. The number of shares has increased by 3.86% in one year.
| Current Share Class | 52.87M |
| Shares Outstanding | 52.87M |
| Shares Change (YoY) | +3.86% |
| Shares Change (QoQ) | +1.07% |
| Owned by Insiders (%) | 19.87% |
| Owned by Institutions (%) | 25.54% |
| Float | 29.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.39 |
| Forward PS | 4.02 |
| PB Ratio | 5.28 |
| P/TBV Ratio | 5.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.60, with a Debt / Equity ratio of 0.63.
| Current Ratio | 9.60 |
| Quick Ratio | 8.63 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.49 |
Financial Efficiency
Return on equity (ROE) is -57.91% and return on invested capital (ROIC) is -22.62%.
| Return on Equity (ROE) | -57.91% |
| Return on Assets (ROA) | -20.47% |
| Return on Invested Capital (ROIC) | -22.62% |
| Return on Capital Employed (ROCE) | -40.76% |
| Weighted Average Cost of Capital (WACC) | 16.69% |
| Revenue Per Employee | $352,093 |
| Profits Per Employee | -$213,472 |
| Employee Count | 216 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, Sight Sciences has paid $40,000 in taxes.
| Income Tax | 40,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +131.07% in the last 52 weeks. The beta is 2.41, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.41 |
| 52-Week Price Change | +131.07% |
| 50-Day Moving Average | 7.56 |
| 200-Day Moving Average | 4.87 |
| Relative Strength Index (RSI) | 42.55 |
| Average Volume (20 Days) | 280,706 |
Short Selling Information
The latest short interest is 1.16 million, so 2.19% of the outstanding shares have been sold short.
| Short Interest | 1.16M |
| Short Previous Month | 983,257 |
| Short % of Shares Out | 2.19% |
| Short % of Float | 3.90% |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $76.05 million and -$46.11 million in losses. Loss per share was -$0.89.
| Revenue | 76.05M |
| Gross Profit | 65.44M |
| Operating Income | -42.56M |
| Pretax Income | -46.07M |
| Net Income | -46.11M |
| EBITDA | -42.00M |
| EBIT | -42.56M |
| Loss Per Share | -$0.89 |
Full Income StatementBalance Sheet
The company has $92.37 million in cash and $40.69 million in debt, with a net cash position of $51.69 million or $0.98 per share.
| Cash & Cash Equivalents | 92.37M |
| Total Debt | 40.69M |
| Net Cash | 51.69M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 64.29M |
| Book Value Per Share | 1.23 |
| Working Capital | 101.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.33 million and capital expenditures -$517,000, giving a free cash flow of -$31.84 million.
| Operating Cash Flow | -31.33M |
| Capital Expenditures | -517,000 |
| Free Cash Flow | -31.84M |
| FCF Per Share | -$0.60 |
Full Cash Flow StatementMargins
Gross margin is 86.05%, with operating and profit margins of -55.96% and -60.63%.
| Gross Margin | 86.05% |
| Operating Margin | -55.96% |
| Pretax Margin | -60.58% |
| Profit Margin | -60.63% |
| EBITDA Margin | -55.23% |
| EBIT Margin | -55.96% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.86% |
| Shareholder Yield | -3.86% |
| Earnings Yield | -13.48% |
| FCF Yield | -9.31% |
Analyst Forecast
The average price target for Sight Sciences is $8.23, which is 27.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.23 |
| Price Target Difference | 27.20% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 9.70% |
| EPS Growth Forecast (5Y) | -15.65% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.94 |
| Piotroski F-Score | 3 |
